tiprankstipranks

Lynne Parshall Insider Profile

53 Followers
Lynne Parshall, Director at Cytokinetics, holds 10.78K shares in Cytokinetics (Ticker: CYTK), holds ― shares in Akcea Therapeutics (Ticker: AKCA), holds ― shares in Foghorn Therapeutics (Ticker: FHTX). Most recently, Lynne Parshall Sold ― shares of Cytokinetics on Sep 01, 2026 for an estimated value of $357.40K.
tipranks
Lynne Parshall

Lynne Parshall
Cytokinetics (CYTK)
Director

Ranked #7,786 out of 108,921 Corporate Insiders

Profitable Transactions

79%
11 out of 14 Profitable Transactions

Average Return

+18.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
79.18%
20.82%
0.00%
A breakdown of Lynne Parshall's holdings

Insider Roles

Ionis Pharmaceuticals
(IONS)
Director
Cytokinetics
(CYTK)
Director
Foghorn Therapeutics
(FHTX)
Director
Roles that Lynne Parshall holds in companies

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Sell
Date:Aug 12, 2024 - Aug 12, 2025
Return:+38.90%
The most profitable trade made by Lynne Parshall

Lynne Parshall's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cytokinetics
Sep 01, 2026
Director
Informative Sell
357.40K
$784.21K
AKCA
Akcea Therapeutics
Foghorn Therapeutics
Director
Ionis Pharmaceuticals
Apr 17, 2026
Director
Uninformative Sell
381.37K
$2.98M
RGLS
Regulus
Oct 11, 2012
Uninformative Buy
$57.52M
List of latest transactions for each holding click on a transaction to see Lynne Parshall's performance on stock

Lynne Parshall insider profile FAQ

What is the percentage of profitable transactions made by Lynne Parshall?
The percentage of profitable transactions made by Lynne Parshall is 79%.
    What is the average return per transaction made by Lynne Parshall?
    The average return per transaction made by Lynne Parshall is 18.80%.
      What stocks does Lynne Parshall hold?
      Lynne Parshall holds: CYTK, AKCA, FHTX, IONS, RGLS stocks.
        What was Lynne Parshall’s latest transaction?
        Lynne Parshall latest transaction was an Informative Sell of $357.40K.
          What was Lynne Parshall's most profitable transaction?
          Lynne Parshall’s most profitable transaction was an Informative Sell of CYTK stock on August 12, 2024. The return on the trade was 38.90%.
            What is Lynne Parshall's role in Cytokinetics?
            Lynne Parshall's role in Cytokinetics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.